LNC Technology Platform

Lipid Nano-Crystal (LNC) Delivery Platform  

Matinas BioPharma's differentiated lipid nano-crystal (LNC) drug delivery platform has the potential to address delivery issues associated with a range of therapeutic types, including small molecules, oligonucleotides, proteins, peptides, vaccines, as well as the targeted delivery of gene editing technologies.

LNC Particles

  • Highly stable lipid nano-crystal particles
  • Layered sheet design provides protection to drug cargo from harsh environmental conditions or enzymes
  • Clinically validated in multiple clinical studies

Ability to Deliver a Broad Range of Molecuels

  • Small molecules
  • Oligonucleotides
  • Proteins
  • Peptides
  • Vaccines
  • Gene editing technologies

For more information about our LNC delivery platform or to find out how we can formulate your drug candidate, please contact us.